Načítá se...
Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy
BACKGROUND: Primary bone cancers are among the deadliest cancer types in adolescents, with osteosarcomas being the most prevalent form. Osteosarcomas are commonly treated with multi-drug neoadjuvant chemotherapy and therapy success as well as patient survival is affected by the presence of tumor sup...
Uloženo v:
| Vydáno v: | BMC Cancer |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4435808/ https://ncbi.nlm.nih.gov/pubmed/25956431 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1397-4 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|